First Rounder: Colin Goddard
First Rounders - Podcast autorstwa Nature Biotechnology
Colin Goddard is former CEO of OSI Pharmaceuticals, and current chairman and CEO of Coferon. His conversation with Nature Biotechnology details the history behind OSI's blockbuster drug Tarceva (erlotinib), the benefits of having a British accent in the United States and how to survive a hostile takeover. Hosted on Acast. See acast.com/privacy for more information.
